rts logo

Which Institutions Own Shares In Intra-Cellular Therapies Inc (ITCI)?

Intra-Cellular Therapies Inc (NASDAQ: ITCI) is 7.92% higher on its value in year-to-date trading and has touched a low of $45.50 and a high of $84.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ITCI stock was last observed hovering at around $74.07 in the last trading session, with the day’s gains setting it 3.22%.

Currently trading at $77.29, the stock is 8.98% and 11.84% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.44 million and changing 4.35% at the moment leaves the stock 19.08% off its SMA200. ITCI registered 26.75% gain for a year compared to 6-month loss of 7.86%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 12.98% gain in the last 1 month and extending the period to 3 months gives it a 12.63%, and is 12.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.36% over the week and 3.99% over the month.

Intra-Cellular Therapies Inc (ITCI) has around 610 employees, a market worth around $8.16B and $513.93M in sales. Fwd P/E is 71.89. Profit margin for the company is -21.57%. Distance from 52-week low is 69.87% and -8.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-18.11%).

The EPS is expected to grow by 63.01% this year

The shares outstanding are 105.58M, and float is at 98.68M with Short Float at 3.78%.

Intra-Cellular Therapies Inc (ITCI) Insider Activity

The most recent transaction is an insider sale by RIGGS RORY B, the company’s Director. SEC filings show that RIGGS RORY B sold 4,462 shares of the company’s common stock on Jun 24 ’24 at a price of $75.57 per share for a total of $0.34 million. Following the sale, the insider now owns 0.12 million shares.

Intra-Cellular Therapies Inc disclosed in a document filed with the SEC on Jun 18 ’24 that VAN NOSTRAND ROBERT L (Director) sold a total of 20,000 shares of the company’s common stock. The trade occurred on Jun 18 ’24 and was made at $75.91 per share for $1.52 million. Following the transaction, the insider now directly holds 9690.0 shares of the ITCI stock.

Still, SEC filings show that on Mar 11 ’24, Mates Sharon (Chairman, President & CEO) disposed off 20,565 shares at an average price of $65.21 for $1.34 million. The insider now directly holds 1,050,309 shares of Intra-Cellular Therapies Inc (ITCI).

Related Posts